United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2021_register
executive
2021-01-23
article
Certain Plant-Derived Recombinant Human Serum Albumins (“rHSA”) and Products Containing Same; Notice of Institution of Investigation
Notices
D09002ee1be6a3f7a
D09002ee1be6a3fef
United States
International Trade Commission
originator
org
United States Government Agency or Subagency
Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on December 16, 2020, under section 337 of the Tariff Act of 1930, as amended, on behalf of Ventria Bioscience Inc. of Junction City, Kansas. Supplements to the complaint were filed on December 16, and 22, 2020. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain plant- derived recombinant human serum albumins (``rHSA'') and products containing same by reason of infringement of certain claims of U.S. Patent No. 10,618,951 (``the '951 patent''); and U.S. Patent No. 8,609,416 (``the '416 patent''). The complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complaint also alleges violations of section 337 based on the importation into the United States, or in the sale of, certain plant-derived recombinant human serum albumins (``rHSA'') and products containing same by reason of false designation of origin, the threat or effect of which is to destroy or substantially injure an industry in the United States. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.
86 FR 6916
https://www.govinfo.gov/app/details/FR-2021-01-25/2021-01439
2021-01439
fr25ja21-51
7020-02-P
Investigation No. 337-TA-1238
https://www.govinfo.gov/app/details/FR-2021-01-25/2021-01439
https://www.govinfo.gov/content/pkg/FR-2021-01-25/html/2021-01439.htm
https://www.govinfo.gov/content/pkg/FR-2021-01-25/pdf/2021-01439.pdf
2 p.
6916
6917
86 FR 6916
Certain Plant-Derived Recombinant Human Serum Albumins (“rHSA”) and Products Containing Same; Notice of Institution of Investigation; Federal Register Vol. 86, Issue
NOTICE
2021-01439
INTERNATIONAL TRADE COMMISSION
Investigation No. 337-TA-1238
7020-02-P
2021-01439
Notice.
Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on December 16, 2020, under section 337 of the Tariff Act of 1930, as amended, on behalf of Ventria Bioscience Inc. of Junction City, Kansas. Supplements to the complaint were filed on December 16, and 22, 2020. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain plant- derived recombinant human serum albumins (``rHSA'') and products containing same by reason of infringement of certain claims of U.S. Patent No. 10,618,951 (``the '951 patent''); and U.S. Patent No. 8,609,416 (``the '416 patent''). The complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complaint also alleges violations of section 337 based on the importation into the United States, or in the sale of, certain plant-derived recombinant human serum albumins (``rHSA'') and products containing same by reason of false designation of origin, the threat or effect of which is to destroy or substantially injure an industry in the United States. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.
Pathenia M. Proctor, The Office of Unfair Import Investigations, U.S. International Trade Commission, telephone (202) 205-2560.
Investigations; Determinations, Modifications, and Rulings, etc.:
Certain Plant-Derived Recombinant Human Serum Albumins and Products Containing Same,
EDIS3Help@usitc.gov
https://edis.usitc.gov
https://www.usitc.gov
Federal Register
Vol. 86, no. 14
Office of the Federal Register, National Archives and Records Administration
2021-01-25
continuing
daily
deposited
born digital
235 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2021-01-25
P0b002ee1aaeb0b74
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr25ja21
https://www.govinfo.gov/app/details/FR-2021-01-25
https://www.govinfo.gov/content/pkg/FR-2021-01-25/pdf/FR-2021-01-25.pdf
https://www.govinfo.gov/content/pkg/FR-2021-01-25/xml/FR-2021-01-25.xml
fdlp
6825
7057
DGPO
2021-01-23
2023-05-25
FR-2021-01-25
machine generated
eng
FR
FR-2021-01-25
86
14